Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 3683 (116th)

COVID–19 Accountability Act

referredUnited States· United States Congress· EN

Introduced

11 May 2020

Last action

11 May 2020 · Introduced

Status

Read twice and referred to the Committee on Finance.

Sponsors

Sen. Graham, Lindsey [R-SC], Sen. Braun, Mike [R-IN], Sen. Daines, Steve [R-MT], Sen. Hyde-Smith, Cindy [R-MS], Sen. Scott, Rick [R-FL], Sen. Tillis, Thomas [R-NC], Sen. Inhofe, James M. [R-OK], Sen. Wicker, Roger F. [R-MS], Sen. Young, Todd [R-IN], Sen. McSally, Martha [R-AZ]

Subjects

Taxation

Source updated

10 January 2026

Taxation

Summary

COVID-19 Accountability Act This bill authorizes sanctions in relation to the Chinese government's response to the COVID-19 (i.e., coronavirus disease 2019) outbreak. It also increases the research tax credit and imposes requirements related to the acquisition of items for the Strategic National Stockpile. The President shall periodically certify to Congress that the Chinese government (1) is cooperating with efforts related to the COVID-19 outbreak, (2) has prohibited wet markets, and (3) has released and dropped all charges for anyone involved in protests in Hong Kong related to COVID-19. If the President cannot make such a certification, the President may (1) impose sanctions on Chinese government officials, entities owned or controlled by the Chinese government, and individuals affiliated with such entities; or (2) prohibit Chinese nationals from obtaining student visas (i.e., F and M visas) or exchange visitor visas (i.e., J visas). With respect to the research tax credit, the bill increases the alternative simplified credit from 14% to 20% of qualified research expenses above a certain threshold. The Department of Health and Human Services generally may not purchase personal protective equipment, critical medical supplies, or certain fabric products not produced in the United States for the Strategic National Stockpile. However, this restriction shall not apply if (1) there is not a sufficient amount of U.S.-produced items available at U.S. market prices when needed, or (2) the purchase is worth less than $150,000.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 11 May 2020

    Introduced

    Read twice and referred to the Committee on Finance.

    Source: IntroReferral

  2. 11 May 2020

    Introduced

    Introduced in Senate

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 11 May 2020

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 11 May 2020

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 11 May 2020

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.